Company Market Research Report: Zimmer Biomet
Company Overview
Name:
Zimmer Biomet
Mission of the Company:
Zimmer Biomet's mission is to alleviate pain and improve the quality of life for people around the world by continuously pushing the boundaries of medical technology innovation.
Founded and Founders:
No information is available.
Key People:
- Hallie Brinkerhuff - Director of Innovation
- Paul Hardy - Regulatory Affairs Director
- David DeMartino - Senior Vice President, Investor Relations
Headquarters:
345 East Main Street, Warsaw, IN 46580, USA
Number of Employees:
Approximately 17,000
Revenue:
No information is available.
Known For:
Zimmer Biomet is known for its innovative portfolio of implants and enabling technologies, which are used in over 100 countries. The company is recognized as a leader in medical technology, significantly contributing to advancements across various stages of the patient journey.
Products
Overview:
Zimmer Biomet offers a wide range of products aimed at improving patient outcomes through innovative support, including implants, digital technology, and infrastructure.
Featured Products:
1. Z1™ Triple-Taper Hip System
- High-level Description: The Z1™ Triple-Taper Hip System is designed for hip replacement surgeries.
- Key Features: No detailed features provided.
2. ROSA® Robotics
- High-level Description: A robotic platform designed to assist surgeons in performing complex surgeries with precision.
- Key Features: Utilizes advanced robotics technology to enhance surgical accuracy.
3. Persona IQ®
- High-level Description: Integrates with knee implants to provide real-time data about the implant's performance.
- Key Features: Offers an innovative solution for personalizing patient care using data analytics.
4. mymobility® Care Management Platform
- High-level Description: A digital care management platform aimed at improving communication and care coordination.
- Key Features: Utilizes data and artificial intelligence to support personalized patient care at home.
5. Persona® OsseoTi® Keel Tibia
- High-level Description: A tibial baseplate designed for knee replacement surgeries.
- Key Features: No detailed features provided.
Recent Developments
Acquisition:
- Zimmer Biomet Signs Definitive Agreement to Acquire OrthoGrid Systems, Inc.
New Product Launches:
- Z1™ Femoral Hip System: This new system, along with clinical data on the G7® Acetabular System, was presented at the 2024 AAHKS Annual Meeting.
Financial Announcements:
- Zimmer Biomet announced its financial results for the second and third quarters of 2024.
- The company has declared quarterly dividends for the third quarter of 2024.
Leadership:
- Appointment of David DeMartino as Senior Vice President of Investor Relations.
- Appointment of Devdatt Kurdikar to the Board of Directors.
Partnerships:
- Zimmer Biomet has partnered with the National Association for the Advancement of Colored People (NAACP), committing $2 million over three years to support efforts against racial injustice and promote diversity and equality.
Industry Presence:
- Zimmer Biomet presented at the Wells Fargo 2024 and Morgan Stanley Annual Global Healthcare Conferences.
Conclusion
Zimmer Biomet continues to exemplify a commitment to innovation and patient care through its robust product offerings and strategic industry engagements. With significant activities in mergers and acquisitions, key leadership appointments, and a focus on social responsibility, the company stands strong in its mission to transform healthcare practices and improve patient outcomes globally.